Effects of Salmeterol on Sleeping Oxygen Saturation in Chronic Obstructive Pulmonary Disease | Zendy

Stephen J. Ryan | Zendy; Liam Doherty | Zendy; Clare Rock | Zendy; Geraldine M. Nolan | Zendy; Walter T. McNicholas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of Salmeterol on Sleeping Oxygen Saturation in Chronic Obstructive Pulmonary Disease

Author(s) -

Stephen J. Ryan,

Liam Doherty,

Clare Rock,

Geraldine M. Nolan,

Walter T. McNicholas

Publication year - 2009

Publication title -

respiration

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.264

H-Index - 81

eISSN - 1423-0356

pISSN - 0025-7931

DOI - 10.1159/000235619

Subject(s) - medicine , salmeterol , copd , placebo , anesthesia , polysomnography , hypercapnia , hypoxemia , bronchodilator , gastroenterology , asthma , respiratory system , apnea , alternative medicine , pathology

Sleep is associated with important adverse effects in patients with chronic obstructive pulmonary disease (COPD), such as disturbed sleep quality and gas exchange, including hypoxemia and hypercapnia. The effects of inhaled long-acting beta(2)-agonist therapy (LABA) on these disturbances are unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research